The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial

BACKGROUND: Fibromyalgia is a chronic multidimensional pain disease with no curative treatment currently available. Its management relies on a multimodal approach involving pharmacologic and non-pharmacologic elements. Because a suggested factor in its etiology is a central sensitization phenomenon...

Descripción completa

Detalles Bibliográficos
Autores principales: Javorcikova, Zuzana, Dangoisse, Michel, Nikis, Stéphane, Lechat, Jean-Paul, Gillain, Aline, Fils, Jean-François, Van der Linden, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627027/
https://www.ncbi.nlm.nih.gov/pubmed/34838114
http://dx.doi.org/10.1186/s13063-021-05814-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627027/
https://www.ncbi.nlm.nih.gov/pubmed/34838114
http://dx.doi.org/10.1186/s13063-021-05814-4

Ejemplares similares